FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996336937> ?p ?o ?g. }

• W1996336937 endingPage "232" @default.
• W1996336937 startingPage "227" @default.
• W1996336937 abstract "Hepatitis C virus (HCV) is prevalent in hemodialysis (HD) patients. The current best therapy for HCV-positive hemodialysis patients is not known. The aim of the present study was to evaluate the long-term efficacy of pegylated interferon (PEG-IFNalpha-2a) in HCV-positive hemodialysis (HD) patients.Twenty-five HCV-RNA-positive hemodialysis patients were included into the study. Twelve patients were allocated to the PEG-IFN treatment group (group 1). Six refused the therapy, and seven were not candidates for kidney transplantation and were allocated to the control group (group 2). All patients underwent chronic hemodialysis treatment for end-stage renal disease during the study period. Group 1 patients received PEG-IFN alpha-2a at a dose of 135 mug weekly for 48 weeks. The patients were prospectively followed up for a period of 192 weeks. Biochemical and virological responses were evaluated at 144 weeks after the completion of therapy. Results. Two patients in group 1 and five patients in group 2 died during 144 weeks of follow-up. SVR was observed in six patients (50%) in group 1 and one patient (1/13) (7.7%) in group 2. ALT levels were normal in 8/10 (80%) in group 1 and in 5/7 (70%) in group 2.In summary, our data showed that treatment of chronic HCV infection in dialysis patients with PEG-IFN alpha-2a at a dose of up to 135 mug weekly was well tolerated. Furthermore, SVR was achieved in half of patients at the end of 144 weeks of follow-up. Our results are encouraging for the administration of PEG-IFN alpha-2a in HCV-positive HD patients waiting for kidney transplantation." @default.
• W1996336937 created "2016-06-24" @default.
• W1996336937 creator A5001969828 @default.
• W1996336937 creator A5009706817 @default.
• W1996336937 creator A5014573953 @default.
• W1996336937 creator A5030194911 @default.
• W1996336937 creator A5035384610 @default.
• W1996336937 creator A5081922046 @default.
• W1996336937 creator A5083889207 @default.
• W1996336937 date "2008-02-01" @default.
• W1996336937 modified "2023-10-16" @default.
• W1996336937 title "Long-Term Efficacy of Pegylated Interferon Alpha-2a in HCV-Positive Hemodialysis Patients" @default.
• W1996336937 cites W158937586 @default.
• W1996336937 cites W1964091672 @default.
• W1996336937 cites W1967535844 @default.
• W1996336937 cites W1975775441 @default.
• W1996336937 cites W1999061416 @default.
• W1996336937 cites W2009046415 @default.
• W1996336937 cites W2023418418 @default.
• W1996336937 cites W2028198363 @default.
• W1996336937 cites W2040140128 @default.
• W1996336937 cites W2066145644 @default.
• W1996336937 cites W2084969400 @default.
• W1996336937 cites W2099216998 @default.
• W1996336937 cites W2106814694 @default.
• W1996336937 cites W2109191005 @default.
• W1996336937 cites W2111180532 @default.
• W1996336937 cites W2113319384 @default.
• W1996336937 cites W2118268231 @default.
• W1996336937 cites W2119806249 @default.
• W1996336937 cites W2139290541 @default.
• W1996336937 cites W2141987606 @default.
• W1996336937 cites W2151471855 @default.
• W1996336937 cites W2158782347 @default.
• W1996336937 cites W2162456167 @default.
• W1996336937 cites W2256687124 @default.
• W1996336937 cites W2262199173 @default.
• W1996336937 cites W2328258639 @default.
• W1996336937 cites W2382132214 @default.
• W1996336937 cites W2427659098 @default.
• W1996336937 cites W2431846095 @default.
• W1996336937 cites W2781301350 @default.
• W1996336937 cites W55697788 @default.
• W1996336937 cites W85042635 @default.
• W1996336937 doi "https://doi.org/10.1080/08860220701813368" @default.
• W1996336937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18300126" @default.
• W1996336937 hasPublicationYear "2008" @default.
• W1996336937 type Work @default.
• W1996336937 sameAs 1996336937 @default.
• W1996336937 citedByCount "16" @default.
• W1996336937 countsByYear W19963369372015 @default.
• W1996336937 crossrefType "journal-article" @default.
• W1996336937 hasAuthorship W1996336937A5001969828 @default.
• W1996336937 hasAuthorship W1996336937A5009706817 @default.
• W1996336937 hasAuthorship W1996336937A5014573953 @default.
• W1996336937 hasAuthorship W1996336937A5030194911 @default.
• W1996336937 hasAuthorship W1996336937A5035384610 @default.
• W1996336937 hasAuthorship W1996336937A5081922046 @default.
• W1996336937 hasAuthorship W1996336937A5083889207 @default.
• W1996336937 hasConcept C126322002 @default.
• W1996336937 hasConcept C141071460 @default.
• W1996336937 hasConcept C203014093 @default.
• W1996336937 hasConcept C2522874641 @default.
• W1996336937 hasConcept C2776408679 @default.
• W1996336937 hasConcept C2776455275 @default.
• W1996336937 hasConcept C2776461080 @default.
• W1996336937 hasConcept C2778063415 @default.
• W1996336937 hasConcept C2778653478 @default.
• W1996336937 hasConcept C2779978075 @default.
• W1996336937 hasConcept C2780040827 @default.
• W1996336937 hasConcept C2911091166 @default.
• W1996336937 hasConcept C54847362 @default.
• W1996336937 hasConcept C71924100 @default.
• W1996336937 hasConcept C90924648 @default.
• W1996336937 hasConceptScore W1996336937C126322002 @default.
• W1996336937 hasConceptScore W1996336937C141071460 @default.
• W1996336937 hasConceptScore W1996336937C203014093 @default.
• W1996336937 hasConceptScore W1996336937C2522874641 @default.
• W1996336937 hasConceptScore W1996336937C2776408679 @default.
• W1996336937 hasConceptScore W1996336937C2776455275 @default.
• W1996336937 hasConceptScore W1996336937C2776461080 @default.
• W1996336937 hasConceptScore W1996336937C2778063415 @default.
• W1996336937 hasConceptScore W1996336937C2778653478 @default.
• W1996336937 hasConceptScore W1996336937C2779978075 @default.
• W1996336937 hasConceptScore W1996336937C2780040827 @default.
• W1996336937 hasConceptScore W1996336937C2911091166 @default.
• W1996336937 hasConceptScore W1996336937C54847362 @default.
• W1996336937 hasConceptScore W1996336937C71924100 @default.
• W1996336937 hasConceptScore W1996336937C90924648 @default.
• W1996336937 hasIssue "2" @default.
• W1996336937 hasLocation W19963369371 @default.
• W1996336937 hasLocation W19963369372 @default.
• W1996336937 hasOpenAccess W1996336937 @default.
• W1996336937 hasPrimaryLocation W19963369371 @default.
• W1996336937 hasRelatedWork W1971562801 @default.
• W1996336937 hasRelatedWork W2012022070 @default.
• W1996336937 hasRelatedWork W2055190024 @default.
• W1996336937 hasRelatedWork W2091664778 @default.

• next